Rich joined Phoremost in 2018. As Vice President of Drug Discovery, Rich has responsibility for PhoreMost’s drug discovery operations which are engaged in progressing first-in-class biological targets identified from the SITESEEKER® platform.
He is a medicinal chemist with over 20 years’ experience in drug discovery in oncology, inflammation and metabolic disease areas. After completing post-doctoral studies in the Chemistry Department at the University of Cambridge, Rich has worked in small and large biotech companies including Millennium Pharmaceuticals, Inpharmatica and Sentinel Oncology.